Two Leading Proxy Advisory Firms Recommend Kindred Stockholders Vote “FOR” the Transaction with TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc.

Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that leading proxy advisory firm Egan-Jones Rating Company (“Egan-Jones”) joined Institutional Shareholder Services (“ISS”) in recommending that Kindred stockholders vote “FOR” the transaction with affiliates of TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. (NYSE: HUM) (together, the “consortium”).

The Kindred Board of Directors is confident that the transaction is in the best interest of all Kindred stockholders and unanimously recommends that stockholders vote “FOR” the value maximizing transaction.

The transaction is the culmination of a robust, 18-month strategic review process conducted by the Kindred Board and management team with the assistance of outside financial advisors and legal counsel. As part of this process, the Kindred Board considered a wide range of options and contacted 15 financial sponsors and three strategic entities regarding their potential interest in the Company. In light of the challenging operating, reimbursement and regulatory environment and the unique dynamics for each of Kindred’s businesses, the Kindred Board strongly believes that now is the right time to enter into a transaction. The Board ultimately determined that the $9.00 per share all-cash transaction maximizes value for stockholders by providing superior risk-adjusted value and certainty compared to all other evaluated opportunities. Kindred strongly urges all stockholders to follow the recommendations of ISS and Egan-Jones and vote “FOR” the value maximizing transaction with the consortium TODAY.

Kindred continues to expect the transaction to close in the summer of 2018.

Kindred’s special meeting of stockholders is scheduled to take place on March 29, 2018 at 10:00 a.m. Eastern Time. Kindred stockholders of record as of the close of business on February 20, 2018 will be entitled to vote their shares either in person or by proxy at the special meeting.

Kindred reminds stockholders that their vote is important, no matter how many shares they own. The Kindred Board unanimously recommends that all Kindred stockholders vote “FOR” the proposal to adopt the merger agreement as well as all other proposals included in the definitive proxy statement. Kindred reminds investors that failing to vote or abstaining from voting is effectively a vote against the transaction.